FR2460137B1 - - Google Patents

Info

Publication number
FR2460137B1
FR2460137B1 FR7917110A FR7917110A FR2460137B1 FR 2460137 B1 FR2460137 B1 FR 2460137B1 FR 7917110 A FR7917110 A FR 7917110A FR 7917110 A FR7917110 A FR 7917110A FR 2460137 B1 FR2460137 B1 FR 2460137B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7917110A
Other languages
French (fr)
Other versions
FR2460137A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR7917110A priority Critical patent/FR2460137A1/fr
Publication of FR2460137A1 publication Critical patent/FR2460137A1/fr
Application granted granted Critical
Publication of FR2460137B1 publication Critical patent/FR2460137B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7917110A 1979-06-29 1979-06-29 Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application Granted FR2460137A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7917110A FR2460137A1 (fr) 1979-06-29 1979-06-29 Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7917110A FR2460137A1 (fr) 1979-06-29 1979-06-29 Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application

Publications (2)

Publication Number Publication Date
FR2460137A1 FR2460137A1 (fr) 1981-01-23
FR2460137B1 true FR2460137B1 (enExample) 1982-11-26

Family

ID=9227381

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7917110A Granted FR2460137A1 (fr) 1979-06-29 1979-06-29 Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application

Country Status (1)

Country Link
FR (1) FR2460137A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
FR2609896B1 (fr) * 1987-01-28 1991-06-28 Bruttmann Georges Nouvelles formes galeniques de gammaglobulines dites anti-inflammatoires pour administration par voie per- et sub-linguale
FR2609897B1 (fr) * 1987-01-28 1991-06-28 Bruttmann Georges Nouvelles formes galeniques de gammaglobulines pour administration par voie per- et sub-linguale
FR2642309A1 (fr) * 1989-01-27 1990-08-03 Fondation Nale Transfusion San Procede de preparation de proteines inhibitrices de la lymphocytotoxicite et du complement et proteines obtenues
NZ229385A (en) * 1989-06-01 1992-02-25 Life Technologies Inc Treatment of processed fish product (surimi) with alpha-2-macroglobulin to neutralise alkaline proteases in the fish
FR3119541A1 (fr) * 2021-02-10 2022-08-12 Marc Bonneau Préparation, propriétés et applications de compositions médicamenteuses contenant des globulines sériques dotées d’activités antivirales

Also Published As

Publication number Publication date
FR2460137A1 (fr) 1981-01-23

Similar Documents

Publication Publication Date Title
FR2448567B1 (enExample)
FR2447615B1 (enExample)
BR8002583A (enExample)
FR2445789B1 (enExample)
BR8006808A (enExample)
FR2448161B1 (enExample)
FR2447531B1 (enExample)
FR2448971B1 (enExample)
FR2460137B1 (enExample)
FR2447463B1 (enExample)
FR2446851B1 (enExample)
FR2447911B1 (enExample)
FR2446599B1 (enExample)
AT364253B (enExample)
FR2448713B1 (enExample)
AU77669S (enExample)
AU78569S (enExample)
AU77763S (enExample)
AU79200S (enExample)
AU79918S (enExample)
AU79950S (enExample)
AU80228S (enExample)
BG28782A1 (enExample)
BG28491A1 (enExample)
BG29934A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse